ライフサイエンスコーパス: bronchoscopic

1 (15 surgical, 2 transthoracic needle, and 1 bronchoscopic).

2 Bronchoscopic abnormalities were classified as none, mil

3 factors and their "cellular localization" in bronchoscopic airway biopsies from patients with COPD, a

4 made conditional recommendations to perform bronchoscopic airway survey, bronchoalveolar lavage, eso

5 DNA was isolated from 55 samples of bronchoscopic alveolar lavage.

6 Oral washes and bronchoscopic alveolar lavages were collected in a stand

7 Results were correlated with the CD4 counts, bronchoscopic and chest radiograph findings.

8 Bronchoscopic and nonbronchoscopic lavage in the same pa

9 We present the radiographic, bronchoscopic, and microbiologic findings within hours a

10 tyrosine] before, immediately and 48 h after bronchoscopic antigen (Ag) challenge of the peripheral a

11 achieved in animals without surgery using a bronchoscopic approach and a novel fibrin-based glue sys

12 ith emphysema, and has generated interest in bronchoscopic approaches that might achieve the same eff

13 ts at the time of transplantation and during bronchoscopic assessments for acute cellular rejection.

14 istently position double-lumen tubes without bronchoscopic assistance.

15 nalyzed pulmonary function tests, blood, and bronchoscopic biopsies from 21 healthy control subjects

16 ies subsequent to a previous percutaneous or bronchoscopic biopsy or previous surgical biopsy or rese

17 dosonographic nodal aspiration compared with bronchoscopic biopsy resulted in greater diagnostic yiel

18 hology, in most cases of samples obtained by bronchoscopic biopsy, should be undertaken by pathologis

19 ar lavage is often used as an alternative to bronchoscopic bronchoalveolar lavage in the diagnosis of

20 We did 150 non-bronchoscopic bronchoalveolar lavages during the course

21 ons occurred in only two patients (4% of the bronchoscopic broncholithectomy group), both with partia

22 nologies to assess basal cells isolated from bronchoscopic brushings of nonsmokers, smokers, and smok

23 Bronchoscopic "cleansing" of the lungs with dilute Surfa

24 chiectasis and history of positive sputum or bronchoscopic culture for target Gram-negative organisms

25 Quantitative bronchoscopic cultures were collected from 62 intubated

26 onkeys for up to 6 months following a single bronchoscopic delivery.

27 cation rates of electromagnetic navigational bronchoscopic (ENB)-guided and computed tomography (CT)-

28 nfirmed absence of collateral ventilation to bronchoscopic endobronchial-valve treatment (EBV group)

29 can often be useful, but invasive testing by bronchoscopic evaluation or acquisition of tissue by one

30 Bronchoscopic examination may be indicated to evaluate v

31 g, and after the provision of anesthesia for bronchoscopic examination of the airway.

32 ermediate-risk patients with a nondiagnostic bronchoscopic examination, a negative classifier score p

33 5 to 98) among patients with a nondiagnostic bronchoscopic examination.

34 A total of 43% of bronchoscopic examinations were nondiagnostic for lung c

35 Eighty-two bronchoscopic examinations were performed on 80 patients

36 tify subphenotypes of asthma by using blood, bronchoscopic, exhaled nitric oxide, and clinical data f

37 uted tomography should be ordered before any bronchoscopic exploration.

38 nchial brushings from 40 participants in the Bronchoscopic Exploratory Research Study of Biomarkers i

39 We conclude that flexible and/or rigid bronchoscopic extraction of partly eroded or free bronch

40 CT findings were correlated with fiberoptic bronchoscopic findings and clinical records.

41 Lymphocyte growth assay was performed on bronchoscopic fragments of tissue cultured in medium wit

42 and group III (n=6) infection was induced by bronchoscopic inoculation of Escherichia coli.

43 approach that utilizes presensitization and bronchoscopic inoculation to reliably produce cavities i

44 pressure and flow tracings before and after bronchoscopic inspection and airway lavage.

45 th low doses of virulent M. tuberculosis via bronchoscopic instillation into the lung.

46 ns and mediastinal lymph nodes with standard bronchoscopic instruments and demonstrate safety.

47 ng volume reduction using nitinol coils is a bronchoscopic intervention inducing regional parenchymal

48 Awake bronchoscopic intubation supported with a noninvasive po

49 ation with a novel technique combining awake bronchoscopic intubation supported with nasally delivere

50 ith more severe disease in studies utilizing bronchoscopic investigative tools.

51 Nonbronchoscopic lavage is not comparable to bronchoscopic lavage and as such cannot be used as an al

52 as such cannot be used as an alternative to bronchoscopic lavage for assessing alveolar inflammation

53 ic lavage could be used as an alternative to bronchoscopic lavage for the assessment of alveolar perm

54 recruited and underwent nonbronchoscopic and bronchoscopic lavage in randomized order.

55 Furthermore, unlike bronchoscopic lavage, nonbronchoscopic lavage was unable

56 spite reports to the contrary, we have found bronchoscopic lung biopsy to be a safe and effective dia

57 the largest series of patients diagnosed by bronchoscopic lung biopsy.

58 ative, less-invasive biopsy methods, such as bronchoscopic lung cryobiopsy (BLC), are highly desirabl

59 Lung volume reduction surgery (LVRS) and bronchoscopic lung volume reduction (bLVR) are palliativ

60 Bronchoscopic lung volume reduction (BLVR), a minimally

61 eview will address the various techniques of bronchoscopic lung volume reduction (BLVR).

62 There were two deaths in the bronchoscopic lung volume reduction group and one contro

63 In the bronchoscopic lung volume reduction group, FEV1 increase

64 laced to achieve unilateral lobar occlusion (bronchoscopic lung volume reduction) or a bronchoscopy w

65 Airway bypass is a bronchoscopic lung-volume reduction procedure for emphys

66 Bronchoscopic lung-volume reduction with the use of one-

67 We reviewed the records of all bronchoscopic procedures at the community hospital from

68 The incorporation of bronchoscopy and bronchoscopic procedures into the investigation of asthm

69 Transbronchial biopsies from 29 bronchoscopic procedures were assessed for rejection.

70 From July 1 to October 31, 2001, 66 bronchoscopic procedures were performed in 60 patients,

71 A diagnosis was obtained in 80.3% of bronchoscopic procedures.

72 k of Pseudomonas aeruginosa infections after bronchoscopic procedures.

73 We reviewed medical charts and bronchoscopic records, examined hospital locations visit

74 Bronchoscopic removal of 71 (56%) broncholiths was attem

75 CT findings were correlated with bronchoscopic results and clinical outcome.

76 CT scans were obtained within 1 week of bronchoscopic sampling in 31 patients receiving mechanic

77 Bronchoscopic sampling of NBECs from smokers and ex-smok

78 CT scans were obtained 1 week or less before bronchoscopic sampling or biopsy in 48 pediatric patient

79 d detect hypoventilation during induction of bronchoscopic sedation and starting bronchoscopy followi

80 cells recruited into the human airway after bronchoscopic segmental allergen challenge of asthmatic

81 subjects with mild allergic asthma underwent bronchoscopic segmental bronchoprovocation with allergen

82 ellows demonstrated that after performing 20 bronchoscopic simulations, the skill level acquired with

83 edictive value of this test, PCR analysis of bronchoscopic specimens may expedite the diagnosis of di

84 ilitated its detection and identification in bronchoscopic specimens.

85 , five cadaveric lung specimens, and virtual bronchoscopic studies in 16 patients.

86 A prospective bronchoscopic study evaluated 14 severe, high-dose oral

87 Protected bronchoscopic techniques (protected specimen brush and b

88 We confirm that invasive bronchoscopic techniques can be performed safely and rel

89 ernative minimally invasive approaches using bronchoscopic techniques including valves, coils, vapour

90 gned and executed research studies utilizing bronchoscopic techniques will significantly add to our k

91 ng the roles of volumetric imaging, advanced bronchoscopic technologies, and limited surgical resecti

92 h severe emphysema followed up for 6 months, bronchoscopic treatment with nitinol coils compared with

93 New bronchoscopic treatments of asthma and emphysema are act

94 f the more diseased upper lobe segments with bronchoscopic vapour ablation led to clinical improvemen

95 d underwent surgical volume reduction (SVR), bronchoscopic volume reduction (BVR), or bronchoscopy al

96 Bronchoscopic washings revealed acid-fast bacilli and we